Overview


According to FutureWise analysis the market for embolic protection devices in 2023 is US$ 1.52 billion, and is expected to reach US$ 2.97 billion by 2031 at a CAGR of 8.72%.

Medical professionals use embolic protection devices to capture and remove emboli, which are blood clots or foreign objects that can break off from a larger clot or plaque and move through the bloodstream. These devices are used during various medical procedures, such as carotid artery stenting, transcatheter aortic valve replacement, and peripheral vascular interventions, to reduce the risk of embolism and associated complications. Embolic protection devices work by capturing and removing any debris that may be dislodged during a procedure, preventing it from traveling to other parts of the body and causing damage. The devices may be designed to capture debris in a filter or to divert the debris away from critical areas.

When a blood clot or other foreign substance like air or fat gets stuck in a blood vessel and obstructs blood flow to a particular area of the body, it's called an embolism. This can lead to tissue damage, organ damage, or even death, depending on the location and severity of the blockage. Embolism can occur in any blood vessel in the body, but it is most commonly associated with the vascular system that supplies blood to the brain, heart, and lungs. If a clot obstructs blood flow to the brain, it can result in a stroke. Similarly, if it blocks blood flow to the heart, it can cause a heart attack. In the lungs, an embolus can cause a pulmonary embolism, which is a life-threatening condition. Preventing embolism is important in many medical procedures, especially those that carry a high risk of embolic events. Embolic protection devices are one way to reduce the risk of embolism and improve patient outcomes.

FutureWise Market Research has published a report that provides an insightful analysis of Embolic Protection Devices Market trends that are affecting the overall market growth. This report will provide a detailed analysis of market share, regional insights, and competitor analysis that includes stature of key manufacturers operational in this industry. By the end of the forecast period FutureWise research analysts projects that Embolic Protection Devices Market will experience a significant growth.

According to the analysis done, this report will help understand the information referring to the total valuation held by this industry. Additionally, this report will help in understanding the growth opportunities held by various segments of this market, further assist in making better strategic and expansion decisions by key stakeholders of an organization.

  • Medtronic 
  • Abbott 
  • Boston Scientific 
  • Cordis (A Cardinal Health Company) 
  • Allium Medical Solutions 
  • Contego Medical 
  • W.L. Gore & Associates 
  • Silk Road Medical 
  • Claret Medical 
  • AngioSlide 
  • Edward Lifesciences
  • Innovative Cardiovascular Solutions
  • Transverse Medical

Recent developments by key players in Embolic Protection Devices Market:

  • In January 2022, Cardiovascular Systems, Inc. recalled the WIRION Embolic Protection Device due to complaints of the filter rupturing during retrieval.

The global market for embolic protection devices is dynamic, with various factors that affect its growth and demand. One of the key drivers of the embolic protection devices market is the increasing prevalence of cardiovascular diseases. Cardiovascular illnesses are a leading cause of mortality worldwide, and many of these diseases require invasive procedures that carry a risk of embolism. As the prevalence of cardiovascular diseases increases, so too does the demand for embolic protection devices. The rise in the aging population is also a significant driver of the embolic protection devices market. As the population age, they are more likely to develop cardiovascular diseases that require invasive procedures. In addition, older patients may be more susceptible to complications from embolism. With the world's aging population on the rise, there is an anticipated increase in the demand for embolic protection devices. The embolic protection devices market is also being driven by the growing use of minimally invasive procedures. Opting for minimally invasive procedures has multiple benefits over conventional open surgeries, such as shorter hospital stays, quicker recovery periods, and decreased chances of complications. However, these procedures often carry a higher risk of embolism, which has led to an increased demand for embolic protection devices.

On the other hand, there are several challenges faced by the embolic protection devices market. One of the main challenges is the high cost of these devices, which can limit their adoption in some regions. Furthermore, there is a shortage of established protocols for the use of embolic protection devices, which can make it difficult for healthcare providers to determine when and how to use them. Another significant issue that healthcare faces is the dearth of proficient healthcare professionals who can use these devices. Embolic protection devices require specialized training and expertise to use effectively, and there may be a shortage of trained healthcare professionals in some regions. This can limit the adoption of these devices and affect the growth of the market.

By Type and Material

  • By Type
    • Distal Filter Devices
    • Distal Occlusion Devices
    • Proximal Occlusion Devices
  • By Material
    • Nitinol
    • Polyurethane

By Application

  • Cardiovascular Diseases
  • Neurovascular Diseases
  • Peripheral Diseases

By Indication

  • Percutaneous Coronary Intervention
  • Carotid Artery Diseases Saphenous Vein Graft Disease
  • Transcatheter Aortic Valve Replacement
  • Other Indications

By End User

  • Hospitals
  • Ambulatory Care Centers

By Region

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa

This market research report also emphasis on factors affecting the growth rate in various regions listed above. A deep-down analysis of region will also be provided in the final version of this market which is based on conclusion of primary interviews and secondary data point gathered during the process.

By region, the market is segmented into North America, Latin America, Europe, Asia-Pacific, and Middle East & Africa. North America registered the highest share in the market in 2022. Throughout the forecast period, North America is expected to dominate the global embolic protection devices market. The highest percentage is mostly attributable to a bigger patient pool and an expanding elderly population.

In addition, well-established insurance plans and the availability of superior healthcare infrastructure are two more factors driving the industry in this region. The United States has the greatest market share in North America due to reasons such as an increasing number of elderly populations and a growing number of patient pools in the country. The Centres for Disease Control and Prevention estimate that 13.7 million individuals had a stroke in 2021, and 5.5 million people died as a result. According to studies, a huge number of patients boosts the market in this region.


  • Tier 1 players- established companies in the market with a major market share
  • Tier 2 players
  • Emerging players which are growing rapidly
  • New Entrants

  • Growth prospects
  • SWOT analysis
  • Key trends
  • Key data-points affecting market growth

  • To provide with an exhaustive analysis on the Embolic Protection Devices Market By Type and Material, By Application, By Indication, By End User and By Region.
  • To cater comprehensive insights on factors such as drivers, restraints, trends, opportunity, and additionally segmental and regional factors impacting market growth.
  • To evaluate current market trends and forecast micro-markets and the overall market projections which are represented in the format of data-sets and ppt.
  • To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
  • To provide information on competitors which includes landscape mapping, technological advancements, R&D spending, news concerning strategic alliances, and new product launches.

  • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
  • The customization Mobility Care offered are free of charge with purchase of any license of the report
  • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents


  • 1.   Market Introduction
    •   1. Objectives of the Study
        2. Market Definition
        3. Market Scope
         3.1. Years Considered for the Study
         3.2. Market Covered
        4. Currency
        5. Limitations
        6. Stakeholders
  • 2.   Research Methodology
    •   1. Research Data
         1.1. Secondary Data
          1.1.1. Key Data from Secondary Sources
         1.2. Primary Data
          1.2.1. Key Data from Primary Sources
        2. Market Size Estimation
        3. Market Breakdown and Data Triangulation
        4. Assumptions for the Study
  • 3.   Executive Summary
    •   1. Market Outlook
        2. Segment Outlook
        3. Competitive Insights
  • 4.   Embolic Protection Devices Market Variables, Trends and Scope
    •   1. Market Lineage Outlook
        2. Penetration and Growth Prospect Mapping
        3. Industry Value Chain Analysis
        4. Cost Analysis Breakdown
        5. Technology Overview
        6. Regulatory Framework
         6.1. Reimbursement Framework
         6.2. Standards and Compliances

  • 5.   Market Overview
    •   1. Market Dynamics
         1.1. Market Driver Analysis
          1.1.1. Increasing focus of Embolic Protection Devices Market Companies on Brand Protection
          1.1.2. Untapped Opportunities in Emerging Regions
         1.2. Market Restraint Analysis
          1.2.1. High Cost Associated with Implementation of Predictive Analysis
         1.3. Industry Challenges
          1.3.1. Presence of Ambiguous Regulatory Framework
  • 6.   Embolic Protection Devices Market Analysis Tools
    •   1. Industry Analysis - Porter’s
         1.1. Supplier Power
         1.2. Buyer Power
         1.3. Substitution Threat
         1.4. Threat from New Entrants
         1.5. Competitive Rivalry
        2. Pestel Analysis
         2.1. Political Landscape
         2.2. Environmental Landscape
         2.3. Social Landscape
         2.4. Technology Landscape
         2.5. Legal Landscape
        3. Major Deals And Strategic Alliances Analysis
         3.1. Joint Ventures
         3.2. Mergers and Acquisitions
         3.3. Licensing and Partnership
         3.4. Technology Collaborations
         3.5. Strategic Divestments
        4. Market Entry Strategies
        5. Case Studies
  • 7.   Embolic Protection Devices Market, By Type and Material Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. By Type
         1.1. Distal Filter Devices
         1.2. Distal Occlusion Devices
         1.3. Proximal Occlusion Devices
        2. By Material
         2.1. Nitinol
         2.2. Polyurethane

  • 8.   Embolic Protection Devices Market, By Application Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Cardiovascular Diseases
        2. Neurovascular Diseases
        3. Peripheral Diseases

  • 9.   Embolic Protection Devices Market, By Indication Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Percutaneous Coronary Intervention
        2. Carotid Artery Diseases Saphenous Vein Graft Disease
        3. Transcatheter Aortic Valve Replacement
        4. Other Indications

  • 10.   Embolic Protection Devices Market, By End User Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Hospitals
        2. Ambulatory Care Centers

  • 11.   North America Embolic Protection Devices Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. U.S.A
         2.2. Canada
         2.3. Mexico
        3. Market Size (USD Million) Forecast for North America 2023-2031

  • 12.   Latin America Embolic Protection Devices Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Brazil
         2.2. Venezuela
         2.3. Argentina
         2.4. Rest of Latin America
        3. Market Size (USD Million) Forecast for Latin America 2023-2031

  • 13.   Europe Embolic Protection Devices Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Germany
         2.2. U.K
         2.3. France
         2.4. Italy
         2.5. Spain
         2.6. Russia
         2.7. Poland
         2.8. Rest of Europe
        3. Market Size (USD Million) Forecast for Europe 2023-2031

  • 14.   Asia Pacific Embolic Protection Devices Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Japan
         2.2. China
         2.3. India
         2.4. Australia and New Zealand
         2.5. ASEAN
         2.6. Rest of Asia Pacific
        3. Market Size (USD Million) Forecast for Asia Pacific 2023-2031

  • 15.   Middle East and Africa Embolic Protection Devices Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. GCC
         2.2. Israel
         2.3. South Africa
         2.4. Rest of MEA
        3. Market Size (USD Million) Forecast for MEA 2023-2031

  • 16.   Market Share Analysis and Competitive Landscape
    •   1. Global Landscape - Key Players, Revenue and Presence
        2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
        3. Global Emerging Companies
        4. North America - Market Share Analysis and Key Regional Players
        5. Europe - Market Share Analysis and Key Regional Players
        6. Asia Pacific - Market Share Analysis and Key Regional Players
        7. Global Key Player - Growth Matrix
  • 17.   Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)
    •   1. Medtronic (Ireland)
         1.1. Company Overview
         1.2. Product Portfolio
         1.3. SWOT Analysis
         1.4. Financial Overview
         1.5. Strategic Overview
        2. Abbott (US)
         2.1. Company Overview
         2.2. Product Portfolio
         2.3. SWOT Analysis
         2.4. Financial Overview
         2.5. Strategic Overview
        3. Boston Scientific (US)
         3.1. Company Overview
         3.2. Product Portfolio
         3.3. SWOT Analysis
         3.4. Financial Overview
         3.5. Strategic Overview
        4. Cordis (A Cardinal Health Company) (US)
         4.1. Company Overview
         4.2. Product Portfolio
         4.3. SWOT Analysis
         4.4. Financial Overview
         4.5. Strategic Overview
        5. Allium Medical Solutions (Israel)
         5.1. Company Overview
         5.2. Product Portfolio
         5.3. SWOT Analysis
         5.4. Financial Overview
         5.5. Strategic Overview
        6. Contego Medical (US)
         6.1. Company Overview
         6.2. Product Portfolio
         6.3. SWOT Analysis
         6.4. Financial Overview
         6.5. Strategic Overview
        7. W.L. Gore & Associates (US)
         7.1. Company Overview
         7.2. Product Portfolio
         7.3. SWOT Analysis
         7.4. Financial Overview
         7.5. Strategic Overview
        8. Silk Road Medical (US)
         8.1. Company Overview
         8.2. Product Portfolio
         8.3. SWOT Analysis
         8.4. Financial Overview
         8.5. Strategic Overview
        9. Claret Medical (US)
         9.1. Company Overview
         9.2. Product Portfolio
         9.3. SWOT Analysis
         9.4. Financial Overview
         9.5. Strategic Overview
        10. AngioSlide (Israel)
         10.1. Company Overview
         10.2. Product Portfolio
         10.3. SWOT Analysis
         10.4. Financial Overview
         10.5. Strategic Overview
        11. Edward Lifesciences
         11.1. Company Overview
         11.2. Product Portfolio
         11.3. SWOT Analysis
         11.4. Financial Overview
         11.5. Strategic Overview
        12. Innovative Cardiovascular Solutions
         12.1. Company Overview
         12.2. Product Portfolio
         12.3. SWOT Analysis
         12.4. Financial Overview
         12.5. Strategic Overview
        13. Transverse Medical
         13.1. Company Overview
         13.2. Product Portfolio
         13.3. SWOT Analysis
         13.4. Financial Overview
         13.5. Strategic Overview

  • 18.   Pre and Post COVID-19 Impact
    •   1. Positive influence on the healthcare industry
        2. The financial disruption of the manufacturing sector
        3. Impact of COVID-19 on emerging companies
        4. Significant mandates in the healthcare regulations initiated by
                  administrations
        5. The overall economic slowdown of the developing and developed nations

  • 19.   FutureWise SME Key Takeaway Points for Client
Partner

Our Clients